These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26048686)

  • 1. Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.
    Epprecht L; Schreglmann SR; Goetze O; Woitalla D; Baumann CR; Waldvogel D
    J Neurol; 2015 Aug; 262(8):1946-53. PubMed ID: 26048686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric emptying time and gastric motility in patients with Parkinson's disease.
    Hardoff R; Sula M; Tamir A; Soil A; Front A; Badarna S; Honigman S; Giladi N
    Mov Disord; 2001 Nov; 16(6):1041-7. PubMed ID: 11748735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.
    Tanaka Y; Kato T; Nishida H; Araki H; Murase M; Nagaki M; Moriwaki H; Inuzuka T
    J Neurol; 2009 Dec; 256(12):1972-6. PubMed ID: 19575260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of gastric emptying in Parkinson's disease.
    Goetze O; Nikodem AB; Wiezcorek J; Banasch M; Przuntek H; Mueller T; Schmidt WE; Woitalla D
    Neurogastroenterol Motil; 2006 May; 18(5):369-75. PubMed ID: 16629864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa Does Not Worsen Gastric Emptying in Parkinson's Disease.
    Shiina S; Sakakibara R; Doi H; Tateno F; Sato M; Masaka T; Kishi M; Tsuyusaki Y; Ogata T; Aiba Y; Tateno H
    J Am Geriatr Soc; 2015 Oct; 63(10):2185-6. PubMed ID: 26480981
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test.
    Goetze O; Wieczorek J; Mueller T; Przuntek H; Schmidt WE; Woitalla D
    Neurosci Lett; 2005 Mar; 375(3):170-3. PubMed ID: 15694254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Gastric Emptying in Advanced Parkinson Disease: Correlation With Therapeutic Doses.
    Bestetti A; Capozza A; Lacerenza M; Manfredi L; Mancini F
    Clin Nucl Med; 2017 Feb; 42(2):83-87. PubMed ID: 27941374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication impairs probabilistic classification learning in Parkinson's disease.
    Jahanshahi M; Wilkinson L; Gahir H; Dharmaindra A; Lagnado DA
    Neuropsychologia; 2010 Mar; 48(4):1096-103. PubMed ID: 20006629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective Perceived Motor Improvement after Acute Levodopa Challenge in Parkinson's Disease.
    Rabel C; Le Goff F; Lefaucheur R; Ozel G; Fetter D; Rouillé A; Maltête D
    J Parkinsons Dis; 2016 Oct; 6(4):779-785. PubMed ID: 27662330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
    Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
    J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levodopa plasma concentration after oral administration predicts levodopa-induced dyskinesia in Parkinson's disease.
    Shiraishi T; Nishikawa N; Mukai Y; Takahashi Y
    Parkinsonism Relat Disord; 2020 Jun; 75():80-84. PubMed ID: 32497995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar).
    Torti M; Alessandroni J; Bravi D; Casali M; Grassini P; Fossati C; Ialongo C; Onofrj M; Radicati FG; Vacca L; Bonassi S; Stocchi F
    Br J Clin Pharmacol; 2019 Nov; 85(11):2605-2613. PubMed ID: 31378952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
    Bachmann CG; Zapf A; Brunner E; Trenkwalder C
    Eur J Neurol; 2009 Aug; 16(8):895-901. PubMed ID: 19374662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
    Kuoppamäki M; Leinonen M; Poewe W
    J Neural Transm (Vienna); 2015 Dec; 122(12):1709-14. PubMed ID: 26347184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
    Ferreira JJ; Rocha JF; Falcão A; Santos A; Pinto R; Nunes T; Soares-da-Silva P
    Eur J Neurol; 2015 May; 22(5):815-25, e56. PubMed ID: 25649051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.